-
The Michael J. Fox Foundation for Parkinson's Research Supports the Obama Administration's Brain Activity Map Initiative
April 2, 2013
… and Francis Collins, director of the National Institutes of Health, in this ambitious effort to create a future where …
-
Functional Evaluation of Alpha-synuclein Dosage Effects in CRISPR‐edited SNCA Model
… Parkinson’s specific neuronal markers. Objectives for Supplemental Investigation: The objectives of the supplemental investigation are to derive additional cell lines to … Furthermore, we will assess cytotoxicity, mitochondrial health, autophagy and neuronal network activity in these …
-
Developing New 18F-based Brain Tracers for Imaging Synapse in the Human Brain
… pre-clinical studies. Step 3: File regulatory submission to Health Canada and the U.S. Food and Drug Administration to …
-
MJFF Board Chairman Publishes Eye-Popping Photography from around the World
May 23, 2019
… living with the disease, care partners, researchers and health care providers with a portion of proceeds benefitting …
-
Phase II Trial of Bone Marrow-Derived Mesenchymal Stem Cells as a Disease-Modifying Therapy for Parkinson’s Disease
… of mesenchymal stem cells from the bone marrow of a healthy donor will significantly slow the progression of … This could slow or stop the disease process and restore health to the brain. Next Steps for Development: The team …
-
Bipolar Disorder and Parkinson’s Disease
… (PPMI) and the Kaiser Permanente Northern California health system (KPNC). In each population, we will determine …